Blog
Director of Business Development, Pannucci Honored as ICBI Advisory Council Member
Check out the below from our press release issued today: Pearl Pathways’ Director of Business Development, Pannucci one of select group of Indianapolis area life science industry executives to make up the ICBI Advisory Council INDIANAPOLIS, INDIANA – March 23, 2016 -...
Debate over biobank donation compensation – what if your genes lead to a blockbuster drug?
Check out this fascinating article in Fast Company authored by Christina Farr debating ethical issues in how biobank donors should be compensated if their DNA leads to a blockbuster discoveries by big pharma. One of the case studies examined is donors whose rare...
FDA’s COA Compendium — a tool for patient focused drug development
Ed Miseta of Clinical Leader, recently wrote an excellent article about FDA’s pilot Clinical Outcome Assessment (COA) Compendium and hit on some good points about what you need to know about it. The FDA defines a COA as a “measure of a patient’s symptoms, overall...
Upcoming Event: 13th annual BioHouston Chili Cook Off, April 1st
Bringing the Houston life science community together, BioHouston is sponsoring a chili competition, spirit, awards, and much more! This event is held on April 1st from 12pm – 4pm at the Bayou City Event Center, Houston TX. For an afternoon of fun and building the life...
On March 7th, Diana Caldwell serving on CEO panel held at Butler University
Butler University is hosting a CEO Panel discussion moderated by Butler MBA Association President, Barry Dunham, on March 7th including Pearl Pathways’ own CEO and President, Diana Caldwell. Caldwell, with other industry experts, will share career reflections and...